The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

In the two-signal model of T cell activation, the outcome of antigen recognition is determined by the integration of multiple cues in the immune microenvironment. mTOR is an evolutionarily conserved PI3-kinase family member that plays a central role in integrating environmental cues in the form of amino acids, energy, and growth factors. Recently, an increasingly important role for mTOR in directing T cell activation and differentiation has become apparent. Here we review recent findings demonstrating the ability of mTOR to interpret signals in the immune microenvironment and program the generation of CD4(+) effector versus regulatory T cells, the generation of CD8(+) effector versus memory cells, T cell trafficking, and T cell activation versus anergy. The key theme to emerge from these studies is that the central role of mTOR provides a direct link between T cell metabolism and function.

[1]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[2]  R. DePinho,et al.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells , 2010, Nature Immunology.

[3]  David K. Finlay,et al.  Phosphoinositide 3‐kinase and the mammalian target of rapamycin pathways control T cell migration , 2010, Annals of the New York Academy of Sciences.

[4]  D. Sabatini mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.

[5]  R. Mills,et al.  T cell dependence on mTOR signaling , 2009, Cell cycle.

[6]  B. Bierer,et al.  Ex Vivo Rapamycin Generates Donor Th2 Cells That Potently Inhibit Graft-versus-Host Disease and Graft-versus-Tumor Effects via an IL-4-Dependent Mechanism1 , 2005, The Journal of Immunology.

[7]  Daniel L. Popkin,et al.  A Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence , 2010, Nature Immunology.

[8]  R. Proia,et al.  S1P1 receptor overrides regulatory T cell-mediated immune suppression through Akt-mTOR , 2009, Nature Immunology.

[9]  M. Jenkins,et al.  The role of cell division in the induction of clonal anergy. , 1992, Immunology today.

[10]  G. Thomas,et al.  Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. , 1999, Current opinion in genetics & development.

[11]  G. de la Rosa,et al.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. , 2007, International immunopharmacology.

[12]  V. Lazar,et al.  FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase1 , 2008, The Journal of Immunology.

[13]  Tobias Schmelzle,et al.  TOR, a Central Controller of Cell Growth , 2000, Cell.

[14]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[15]  Ying Wang,et al.  Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. , 2010, The Journal of clinical investigation.

[16]  Erika L. Pearce Metabolism in T cell activation and differentiation. , 2010, Current opinion in immunology.

[17]  A. Khoruts,et al.  De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR , 2008, Journal of leukocyte biology.

[18]  K. Frauwirth,et al.  Regulation of T lymphocyte metabolism , 2004, Brain, Behavior, and Immunity.

[19]  Kathy O. Lui,et al.  Infectious tolerance via the consumption of essential amino acids and mTOR signaling , 2009, Proceedings of the National Academy of Sciences.

[20]  V. Basso,et al.  Clonal Anergy Is Maintained Independently of T Cell Proliferation1 , 2002, The Journal of Immunology.

[21]  M. Battaglia,et al.  Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.

[22]  M. Merkenschlager,et al.  PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors , 2010, The Journal of experimental medicine.

[23]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[24]  M. Horton,et al.  The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction1 , 2004, The Journal of Immunology.

[25]  T. Whiteside,et al.  Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin , 2009, PloS one.

[26]  P. Linsley,et al.  Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Russell G. Jones,et al.  Revving the engine: signal transduction fuels T cell activation. , 2007, Immunity.

[28]  C. Proud,et al.  Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. , 2003, The Biochemical journal.

[29]  Chin-Lee Wu,et al.  Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. , 2009, Cancer research.

[30]  David M Sabatini,et al.  Defining the role of mTOR in cancer. , 2007, Cancer cell.

[31]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[32]  Qingsheng Li,et al.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. , 2010, Immunity.

[33]  A. Khoruts,et al.  Antagonistic Roles for CTLA-4 and the Mammalian Target of Rapamycin in the Regulation of Clonal Anergy: Enhanced Cell Cycle Progression Promotes Recall Antigen Responsiveness1 , 2001, The Journal of Immunology.

[34]  D. Harlan,et al.  Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy , 2002, The Lancet.

[35]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[36]  M. Boothby,et al.  Sequence Motifs in IL-4Rα Mediating Cell-Cycle Progression of Primary Lymphocytes1 , 2005, The Journal of Immunology.

[37]  C. June,et al.  Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin1 , 2008, The Journal of Immunology.

[38]  C. Janeway Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[39]  David M. Sabatini,et al.  The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.

[40]  C. Spencer,et al.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. , 2010, Immunity.

[41]  G. Szot,et al.  Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes , 2009, Diabetes.

[42]  Y. Ip,et al.  Regulators of the Toll and Imd pathways in the Drosophila innate immune response. , 2005, Trends in immunology.

[43]  L. Platanias,et al.  Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. , 2004, Experimental cell research.

[44]  Anne F. Buckley,et al.  Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc–dependent pathway , 2001, Nature Immunology.

[45]  Greg M. Delgoffe,et al.  mTOR: taking cues from the immune microenvironment , 2009, Immunology.

[46]  Ming You,et al.  TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.

[47]  D. Sabatini,et al.  mTOR signaling at a glance , 2009, Journal of Cell Science.

[48]  R. Ahmed,et al.  The role of mTOR in memory CD8+ T‐cell differentiation , 2010, Immunological reviews.

[49]  B. Levine,et al.  T Regulatory Expansion and Function CD 28 Costimulation Is Essential for Human June and , 2008 .

[50]  A. Sharpe Mechanisms of costimulation , 2009, Immunological reviews.

[51]  E. Wherry,et al.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin , 2005, Nature Immunology.

[52]  C. Benoist,et al.  The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.

[53]  Loise M. Francisco,et al.  OR.100. PD-L1 Regulates the Development, Maintenance and Function of Induced-regulatory T Cells , 2009 .

[54]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[55]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[56]  B. Levine,et al.  CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function1 , 2008, The Journal of Immunology.

[57]  B. Edgar,et al.  Rheb promotes cell growth as a component of the insulin/TOR signalling network , 2003, Nature Cell Biology.

[58]  P. Matzinger,et al.  Is cancer dangerous to the immune system? , 1996, Seminars in immunology.

[59]  M. V. Heiden,et al.  The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. , 2000, Immunity.

[60]  David M. Sabatini,et al.  An Emerging Role of mTOR in Lipid Biosynthesis , 2009, Current Biology.

[61]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[62]  Corey M. Carlson,et al.  Kruppel-like factor 2 regulates thymocyte and T-cell migration , 2006, Nature.

[63]  Volkmar Braun,et al.  Colicins: structures, modes of action, transfer through membranes, and evolution , 1994, Archives of Microbiology.

[64]  L. Cantley,et al.  Rheb fills a GAP between TSC and TOR. , 2003, Trends in biochemical sciences.

[65]  K. Shokat,et al.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR , 2008, Proceedings of the National Academy of Sciences.

[66]  M. Boothby,et al.  Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes. , 2005, Journal of immunology.

[67]  R. Proia,et al.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.

[68]  K. Inoki,et al.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling , 2008, The EMBO journal.

[69]  T. Gajewski,et al.  Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells , 2008, European journal of immunology.

[70]  G. Filomeni,et al.  Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Jonathan D. Powell,et al.  Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. , 2009, The New England journal of medicine.

[72]  Y. Toda,et al.  Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[73]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[74]  M. Rossi,et al.  IL-4 regulates susceptibility to intestinal inflammation in murine food allergy Running head : IL-4 in allergic intestinal inflammation , 2008 .

[75]  E. Wherry,et al.  Cutting Edge: IL-12 Inversely Regulates T-bet and Eomesodermin Expression during Pathogen-Induced CD8+ T Cell Differentiation1 , 2006, The Journal of Immunology.

[76]  Greg M. Delgoffe,et al.  Anergic T Cells Are Metabolically Anergic1 , 2009, The Journal of Immunology.

[77]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[78]  I. Kang,et al.  AICAR suppresses IL-2 expression through inhibition of GSK-3 phosphorylation and NF-AT activation in Jurkat T cells. , 2005, Biochemical and biophysical research communications.

[79]  J. Modiano,et al.  Negative regulators in homeostasis of naïve peripheral T cells , 2008, Immunologic research.

[80]  R. Schwartz T cell anergy. , 1993, Scientific American.

[81]  K. Lafferty,et al.  A new analysis of allogeneic interactions. , 1975, The Australian journal of experimental biology and medical science.

[82]  N. Hay,et al.  The two TORCs and Akt. , 2007, Developmental cell.

[83]  David K. Finlay,et al.  Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking , 2008, Nature Immunology.

[84]  C. Janeway,et al.  How does the immune system distinguish self from nonself? , 2000, Seminars in immunology.

[85]  S. Schreiber,et al.  Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M. Matsuo,et al.  Inhibition of amino acid-mTOR signaling by a leucine derivative induces G1 arrest in Jurkat cells. , 2003, Biochemical and biophysical research communications.

[87]  R. D. Hatton,et al.  Developmental plasticity of Th17 and Treg cells. , 2009, Current opinion in immunology.

[88]  C. Thompson,et al.  IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1 , 2001, The Journal of Immunology.

[89]  V. Basso,et al.  Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of Rapamycin1 , 2006, The Journal of Immunology.

[90]  J. Curtsinger,et al.  Inflammatory cytokines as a third signal for T cell activation. , 2010, Current opinion in immunology.

[91]  J. Powell,et al.  Dissecting the mechanism of T-cell anergy with immunophilin ligands. , 2006, Current opinion in investigational drugs.

[92]  Daniel R. Beisner,et al.  Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor , 2009, Nature Immunology.

[93]  Russell G. Jones,et al.  Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.

[94]  Loise M. Francisco,et al.  PD-L1 regulates the development, maintenance, and function of induced regulatory T cells , 2009, The Journal of experimental medicine.

[95]  P. Worley,et al.  Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals , 1997, Molecular and cellular biology.

[96]  R. Negrin,et al.  Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. , 2008, Blood.

[97]  K. Frauwirth,et al.  Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.

[98]  C. Barnes,et al.  rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. , 1994, The Journal of biological chemistry.

[99]  C. Proud,et al.  Amino acids and mTOR signalling in anabolic function. , 2007, Biochemical Society transactions.

[100]  Shailendra Giri,et al.  5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[101]  T. Weichhart,et al.  The multiple facets of mTOR in immunity. , 2009, Trends in immunology.

[102]  V. Kuchroo,et al.  Th17: the third member of the effector T cell trilogy. , 2007, Current opinion in immunology.

[103]  V. Basso,et al.  Mammalian Target of Rapamycin through Signaling Mediated by the IL-2-Independent T Cell Clonal Expansion Prolonged TCR / CD 28 Engagement Drives , 2006 .

[104]  R. Schwartz,et al.  Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. , 1999, Journal of immunology.

[105]  W. Hörl,et al.  The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.